1. re PDUFA action date of 30 September 2020, positive FDA news for others (here's hoping):
https://endpts.com/incyte-nabs-2nd-ever-approval-ahead-of-schedule-as-fda-insists-it-can-still-review-on-time/
2. re planned Advisory Committee Meeting, looks like a relevant 8 May 2020 meeting but MSB not on the draft agenda, and the draft roster looks a bit lightweight to me (no offense intended):
https://www.fda.gov/advisory-committees/advisory-committee-calendar/cellular-tissue-and-gene-therapies-advisory-committee-may-8-2020-meeting-announcement-05082020
GLTAH!
Ann: FDA Accepts BLA for RYONCIL and Agrees to Priority Review, page-123
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22000 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 36989 | 4 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |